Tender detail

Crizotinib-containing tyrosine kinase inhibitor

Summary

The University Hospital Ostrava and the University Hospital Hradec Králové are procuring recurring deliveries of a crizotinib-containing tyrosine kinase inhibitor in 200 mg and 250 mg hard capsules. The contract covers a 48-month supply, with an estimated value of CZK 7,962,966.53.

Reference number
790827-2026
Buyer
Fakultní nemocnice Ostrava
Country
Czechia (CZE)
Procedure
Open procedure
CPV
33652100 Antineoplastic agents
Deadline
2026-12-15
Status
Open
Contract subject
Supplies
Estimated value
7 962 966,53 CZK
Source
TED

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.